D. Louis

Molecular Biology · 2000–2021

A researcher in the Science corpus: 23 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Molecular Biology — 176 citations into it; #16,601 of 17,773 by trust here, #2,461 by citations
• Cancer Research — 96 citations into it; #1,558 of 1,780 by trust here, #338 by citations
• Oncology — 96 citations into it

Whom D. Louis trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. P. Kleihues
2. H. Ohgaki
3. J. S. Rao

Who trusts D. Louis overall

1. Michael Weller
2. H. Ohgaki
3. Q. Ostrom
4. Guido Reifenberger
5. Richard J. Chen
6. Liu Jin
7. Svitlana Tyekucheva
8. P. Wen
9. M. Sofroniew
10. P. Kleihues

Papers from D. Louis's perspective

Ordered by how strongly the researchers D. Louis trusts endorse each paper. Same corpus, a different order for every researcher.

1. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. (Cancer Cell)
2. Prediction of central nervous system embryonal tumour outcome based on gene expression (Nature)
3. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. (The Lancet)
4. Identification of a cancer stem cell in human brain tumors. (Cancer Research)
5. MGMT gene silencing and benefit from temozolomide in glioblastoma. (New England Journal of Medicine)
6. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. (Cancer Cell)
7. Pathology and genetics of tumours of the nervous system.
8. Stem cells, cancer, and cancer stem cells (Nature)
9. Molecular subgroups of medulloblastoma: the current consensus (Acta Neuropathologica)
10. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. (New England Journal of Medicine)

Their papers

• Malignant astrocytic glioma: genetics, biology, and paths to treatment. (2007) — 2,428 citations
• Prediction of central nervous system embryonal tumour outcome based on gene expression (2002) — 2,465 citations
• AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. (2007) — 1,814 citations
• Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma (2016) — 1,053 citations
• Reconstructing and reprogramming the tumor propagating potential of glioblastoma stem-like cells (2014) — 887 citations
• Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq (2017) — 879 citations
• Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor Cells (2013) — 1,059 citations
• The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. (2021) — 9,662 citations
• cIMPACT-NOW Update 3: Recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV” (2018) — 744 citations
• The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary (2016) — 14,109 citations
• Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets (2015) — 932 citations
• Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma (2014) — 4,432 citations
• Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma (2011) — 963 citations
• Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. (2011) — 708 citations
• The 2007 WHO Classification of Tumours of the Central Nervous System (2007) — 12,930 citations
• WHO classification of tumours of the central nervous system (2007) — 3,747 citations
• The 2007 WHO classification of tumours of the central nervous system (2007) — 605 citations
• Molecular pathology of malignant gliomas. (2006) — 679 citations
• Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. (2003) — 970 citations
• Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. (2002) — 715 citations